Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,324,919
+$1,694,088 QoQ
Shares Held
6,107
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
4.62%
of 13F equity value
Holder Rank
#1,437
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. LLY ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,324,919 | 6,107 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $5,630,831 | 6,122 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $6,660,867 | 6,198 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,837,420 | 6,340 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,867,385 | 6,244 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $5,230,488 | 6,333 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $6,326,540 | 8,195 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $7,412,659 | 8,367 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $7,674,000 | 8,476 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,916,064 | 8,890 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $5,946,949 | 10,202 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,570,038 | 10,370 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,675,595 | 12,102 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,433,552 | 12,910 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $4,629,339 | 12,654 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,371,368 | 13,519 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $4,466,916 | 13,777 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $3,975,961 | 13,884 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,778,137 | 13,678 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,399,669 | 14,714 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,366,140 | 14,666 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,725,703 | 14,590 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,586,628 | 15,320 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,490,630 | 30,338 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,824,388 | 17,203 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,316,485 | 16,699 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||